⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29700591 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL16400760 | 0.98 | LOXL2 (0.45) | — | |
| Hydrochloric Acid SCHEMBL23088354 | 0.98 | LOXL2 (0.45) | — | |
| SCHEMBL11378229 | 0.83 | HRH1 (0.50) | — | |
| Hydrochloric Acid SCHEMBL14157230 | 0.81 | HRH1 (0.48) | — | |
| SCHEMBL11274198 | 0.79 | FERMT2 (0.49) | — | |
| SCHEMBL29774155 | 0.79 | — | — | |
| SCHEMBL509733 | 0.79 | — | — | |
| SCHEMBL721684 | 0.77 | — | — | |
| SCHEMBL29705223 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3515892-B1 | COMPOUNDS AND METHODS FOR IDO AND TDO MODULATION, AND INDICATIONS THEREFOR | PLEXXIKON INC (US) | 2026-04-15 | — | — | EP | disclosed |
| US-20260092045-A1 | SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2026-04-02 | — | — | US | disclosed |
| US-12581252-B2 | Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitors | RELAY THERAPEUTICS, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-12558341-B2 | Oral complement factor D inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| EP-4689155-A1 | USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS | Astrazeneca AB (SE) | 2026-02-11 | — | — | EP | disclosed |
| US-20260028333-A1 | NEW COMPOUNDS | VICORE PHARMA AB (SE) | 2026-01-29 | — | — | US | disclosed |
| EP-4630410-A1 | POLQ INHIBITORS | Astrazeneca AB (SE) | 2025-10-15 | — | — | EP | disclosed |
| US-12435072-B2 | Compounds | VICORE PHARMA AB (SE) | 2025-10-07 | — | — | US | disclosed |
| US-12414954-B2 | POLQ inhibitors | ASTRAZENECA AB (SE) | 2025-09-16 | — | — | US | disclosed |
| US-20250195530-A1 | POLQ INHIBITORS | ASTRAZENECA AB (SE) | 2025-06-19 | — | — | US | disclosed |
| EP-0256990-A1 | Pyridinio compounds | CIBA-GEIGY AG (CH) | 1988-02-24 | — | — | EP | disclosed |
| US-4352760-A | Organic compounds substituted heptadeca-5,9- and 5,10-dienoic acid | THE UPJOHN COMPANY (US) | 1982-10-05 | — | — | US | disclosed |
| US-4349690-A | ANTISECRETORY, ANTIULCER AGENTS, ANTICOAGULANTS AND ANTIAGGLOMERANTS | THE UPJOHN COMPANY (US) | 1982-09-14 | — | — | US | disclosed |
| US-4301078-A | SMOOTH MUSCLE STIMULATORS | THE UPJOHN COMPANY (US) | 1981-11-17 | — | — | US | disclosed |
| US-4275213-A | Isoxazolyl derivatives of 9α,11α-epoxy imino-9,11,15-trideoxy-PGF-type compounds | THE UPJOHN COMPANY (US) | 1981-06-23 | — | — | US | disclosed |
| US-4131738-A | 6-Hydroxy-PGE1 compounds | THE UPJOHN COMPANY (US) | 1978-12-26 | — | — | US | disclosed |
| US-4112224-A | PROSTAGLANDIN | THE UPJOHN COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
| US-4109082-A | PROSTACYCLIN ANALOGS; SMOOTH MUSCLE STIMULATORS | THE UPJOHN COMPANY (US) | 1978-08-22 | — | — | US | disclosed |
| US-4100192-A | Inter-phenylene-PG amides | THE UPJOHN COMPANY (US) | 1978-07-11 | — | — | US | disclosed |
| US-4097489-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1978-06-27 | — | — | US | disclosed |